Non-invasive procedure

Global Aesthetic Medicine Market (2022-2027): Technological Advancements Associated with Medical Aesthetic Devices Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 29, 2022
General Health, Health, Other Health, Growth, Ansoff Matrix, Elective surgery, Hospital, Risk, Non-invasive procedure, USD, Geography, Day, SWOT, Invasive procedure, Dermatologic Clinics, Market development, Investment, Toy, Female, Male, Gender

The Global Aesthetic Medicine Market is estimated to be USD 98.7 Bn in 2022 and is expected to reach USD 157.52 Bn by 2027, growing at a CAGR of 9.80%

Key Points: 
  • The Global Aesthetic Medicine Market is estimated to be USD 98.7 Bn in 2022 and is expected to reach USD 157.52 Bn by 2027, growing at a CAGR of 9.80%
    The Global Aesthetic Medicine Market is segmented based on Type, Gender, End-Users, and Geography.
  • By End-Users, the market is classified into Ambulatory Surgical Center, Beauty Center & Medical Spa, Dermatology Clinic, Home Setting, and Hospital.
  • The report presents a detailed Ansoff matrix analysis for the Global Aesthetic Medicine Market.
  • The analyst analyses the Global Aesthetic Medicine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

The Worldwide Medical Electronics Industry is Projected to Reach $9.6 Billion by 2027

Retrieved on: 
Friday, June 24, 2022
Becton, Dickinson and Company headquarters, Boston Scientific, Ansoff Matrix, Porter's five forces analysis, USD, Flow measurement, Emotion, Medical procedure, Impact, Competitive analysis, Geography, COVID-19, Market development, SHAKTI - Microprocessor & Microcontroller, Others, Growth, Company, Industry, Invasive procedure, Monitoring, Non-invasive procedure, Risk, Classification, Investment, CAGR, Baxter International, RGM, Ventilator, Battery, Cardiology, Medical imaging, Component, SWOT, Observation, Therapy, Analog Devices, Medical device, Retail, Risk management, Pharmaceutical industry, Display device, Application

The Global Medical Electronics Market is estimated to be USD 6.8 Bn in 2022 and is projected to reach USD 9.63 Bn by 2027, growing at a CAGR of 7.2%.

Key Points: 
  • The Global Medical Electronics Market is estimated to be USD 6.8 Bn in 2022 and is projected to reach USD 9.63 Bn by 2027, growing at a CAGR of 7.2%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Medical Electronics Market stakeholders.
  • The Global Medical Electronics Market is segmented based on Component, End-User Product, Medical Procedure, Medical Device Classification, Application, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Medical Electronics Market.

Global Medical Electronics Market (2022 to 2027) - Advances in Sensors and Digital Technologies Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 23, 2022
Medical Devices, Health, Classification, CAGR, Medical imaging, Industry, Others, Ansoff Matrix, Medical procedure, Observation, Battery, Flow measurement, RGM, Competitive analysis, Non-invasive procedure, COVID-19, Monitoring, Growth, USD, Emotion, Investment, Market development, SWOT, SHAKTI - Microprocessor & Microcontroller, Geography, Invasive procedure, Ventilator, Cardiology, Impact, Porter's five forces analysis, Therapy, Component, Risk, Medical device, Retail, Risk management, Pharmaceutical industry, Display device, Application

Market dynamics are forces that impact the prices and behaviors of the Global Medical Electronics Market stakeholders.

Key Points: 
  • Market dynamics are forces that impact the prices and behaviors of the Global Medical Electronics Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Medical Electronics Market.
  • The analyst analyses the Global Medical Electronics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The Global Medical Electronics Market is segmented based on Component, End-User Product, Medical Procedure, Medical Device Classification, Application, and Geography.

Integrity Health Corporation (OTC: FTEG) Proudly Acquires Medical Aesthetics Solutions (DBA Point Lumineux MedSpa)

Retrieved on: 
Wednesday, August 4, 2021
Invasive procedure, Non-invasive procedure, Minimally invasive procedure

PHOENIX, AZ, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Integrity Health Corporation (the Company) (OTC: FTEG) is very pleased to announce the acquisition of Medical Aesthetics Solutions (DBA Point Lumineux MedSpa) https://www.pointlumineux.com , providing full spectrum of minimally/non-invasive cosmetic procedures and spa services in Sarasota, FL.

Key Points: 
  • PHOENIX, AZ, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Integrity Health Corporation (the Company) (OTC: FTEG) is very pleased to announce the acquisition of Medical Aesthetics Solutions (DBA Point Lumineux MedSpa) https://www.pointlumineux.com , providing full spectrum of minimally/non-invasive cosmetic procedures and spa services in Sarasota, FL.
  • The signing with Point Lumineux MedSpa is to not only join forces with a leading provider of minimally/non-invasive procedures and spa services with their Functional Medicine Solutions but also to embrace their metaphysical approach.
  • Integrity Health Corporations (FTEG) CEO, Nelson Grist, said, Point Lumineux MedSpas approach to healing through careful attention to the mind, body, and spirit connection and providing customized solutions to help each patient achieve their goals is one of the many reasons Point Lumineux MedSpa is a perfect acquisition for Integrity Health.
  • Expectations of Point Lumineux MedSpa includes a variety of services, all based on natural and functional medicine.

 Three New Patents for Know Labs Expand IP Portfolio and Signal Further Applications for Bio-RFID™

Retrieved on: 
Tuesday, July 27, 2021
Professional services, Health, Medical devices, Diabetes, Legal, General Health, Biotechnology, Automatic identification and data capture, Privacy, Radio-frequency identification, Ubiquitous computing, Wireless, Non-invasive procedure, Electrical engineering, Telecommunications, Computing

These new patents expand Know Labs intellectual property portfolio in radio frequency and microwave spectroscopy, further improving its technological position as it readies to launch non-invasive diagnostic devices.

Key Points: 
  • These new patents expand Know Labs intellectual property portfolio in radio frequency and microwave spectroscopy, further improving its technological position as it readies to launch non-invasive diagnostic devices.
  • While we remain sharply focused on diagnostic medical device applications for Bio-RFID, these new patents, combined with our current portfolio, enhance Know Labs position beyond the diagnostic realm and its potential for non-medical applications, said Phil Bosua, Bio-RFID inventor and Know Labs CEO.
  • Our IP portfolio covers more than 100 different analytes, which means Know Labs can offer valuable diagnostic solutions beyond glucose monitoring devices.
  • Each of the newly issued patents relates to the unique configuration of the antennas used in Know Labs Bio-RFID sensors.

Echosens Highlights New EASL Clinical Practice Guidelines: Unprecedented Recommendation for Non-Invasive FibroScan and Care Management

Retrieved on: 
Thursday, July 22, 2021
Managed care, Software, General Health, Radiology, Data management, Technology, Medical devices, Hospitals, Cardiology, Biotechnology, Practice Management, Health, Diabetes, Clinical medicine, Medicine, Medical imaging, Medical specialties, Elastography, Hepatology, Liver disease, Non-invasive procedure, Liver, Liver biopsy

These guidelines represent a significant advance for the non-invasive management of patients with liver diseases and an unprecedented level of recommendation for Echosens solutions.

Key Points: 
  • These guidelines represent a significant advance for the non-invasive management of patients with liver diseases and an unprecedented level of recommendation for Echosens solutions.
  • Liver stiffness measurement (LSM) by transient elastography (TE) received support from 13 strong recommendations and four other recommendations or supportive statements.
  • Pioneer in its field, Echosens significantly changed the practice of liver assessment with FibroScan, the non-invasive solution for comprehensive management of liver health.
  • Echosens has made FibroScan available in over 100+ countries enabling millions of liver examinations worldwide.

Global $18.65 Billion Non-Invasive Aesthetic Treatment Market Forecast to 2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 15, 2021
Cosmetics, Retail, Pharmaceutical, Health, Medicine, Medical procedures, Medical terminology, Minimally invasive procedure, Non-invasive procedure

The "Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Procedure and End-User, and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Procedure and End-User, and Geography" report has been added to ResearchAndMarkets.com's offering.
  • However, clinical risks and complications associated with medical aesthetic procedures are hindering the non-invasive aesthetic treatment market growth.
  • Based on procedure, the non-invasive aesthetic treatment market is segmented into injectables, skin rejuvenation, and others.
  • Based on end user, the non-invasive aesthetic treatment market is segmented into hospitals, clinics and medical spas, and others.

Esaote presents MyLab™X75, latest technology ultrasound system to enhance daily productivity and comfort, making ultrasound imaging easier

Retrieved on: 
Friday, May 28, 2021
Esaote, Acoustics, Ultrasound, Non-invasive procedure, Magnetic resonance imaging, Economy of Italy, Applied sciences, Physics

GENOA, Italy, May 28, 2021 /PRNewswire/ -- Esaote, the Italian leading company in the biomedical field - ultrasound, dedicated MRI, and healthcare IT - is launching the new MyLabX75 ultrasound system.

Key Points: 
  • GENOA, Italy, May 28, 2021 /PRNewswire/ -- Esaote, the Italian leading company in the biomedical field - ultrasound, dedicated MRI, and healthcare IT - is launching the new MyLabX75 ultrasound system.
  • "In the world of imaging and non-invasive diagnostics innovation is key," says Eugenio Biglieri, Esaote COO.
  • Distinguished guests such as the professional alpinist Herv Barmasse and emeritus medical experts participate in and contribute to the event.
  • The Esaote Group is a leader in the biomedical equipment sector, in particular in the areas of ultrasound, dedicated magnetic resonance imaging and software for managing the diagnostic process.

Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS Guidance

Retrieved on: 
Tuesday, May 18, 2021
Medicine, Medical terminology, Respiratory therapist, Teleflex, Spirometer, Minimally invasive procedure, Cardiology, Interventional cardiology, Non-invasive procedure

The Teleflex respiratory product lines that will be divested include oxygen and aerosol therapy, active humidification, non-invasive ventilation, and incentive spirometers, which generated $139 million in revenue in 2020.

Key Points: 
  • The Teleflex respiratory product lines that will be divested include oxygen and aerosol therapy, active humidification, non-invasive ventilation, and incentive spirometers, which generated $139 million in revenue in 2020.
  • We look forward to providing a full financial update to investors on our second quarter 2021 earnings call.
  • Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care.
  • Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.

MRI in Crohn's Disease: Site Set-up and MREn Scoring Systems, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, April 22, 2021
Magnetic resonance imaging, Medicine, Magnetic resonance enterography, Clinical medicine, Radiology, Medical physics, Physical sciences, Non-invasive procedure, Enterography, Radiation therapy

MRI in the abdomen is non-invasive, utilized non-ionizing radiation and permits varying contrast agents.

Key Points: 
  • MRI in the abdomen is non-invasive, utilized non-ionizing radiation and permits varying contrast agents.
  • Magnetic resonance enterography (MREn) can be used as a complement to endoscopy with the advantage of evaluating sub-surface features of CD.
  • Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)
  • Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.\nSydney Perelmutter, Xtalks, +1 (416) 977-6555 x 352, [email protected]\n"